Perpetual Observational Studies: New strategies to support efficient implementation of observational studies and randomized trials in the infectious diseases arena

Autor: Hassoun-Kheir, N., van Werkhoven, C. H., Dunning, J., Jaenisch, T., van Beek, J., Bielicki, J., Butler, C., Francois, B., Harbarth, S., Padilla, A. C. Hernandez, Horby, P., Koopmans, M., Lee, J., Rodriguez-Baño, J., Tacconelli, E., Themistocleous, Y., van der Velden, A. W., Bonten, M., Goossens, H., de Kraker, M. E. A.

The increasing threat of emerging infectious diseases and antimicrobial resistance requires more efficient, high-quality research. Perpetual Observational Studies (POS) nested within a clinical research network can improve planning, quality and effic

Externí odkaz: http://arxiv.org/abs/2208.03992

Expert consensus on antimicrobial resistance research priorities to focus development and implementation of antibacterial vaccines and monoclonal antibodies.

Autor: Hassoun-Kheir N; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, WHO Collaborating Center, Geneva, Switzerland., Guedes M; Infection and Antimicrobial Resistance Control and Prevention Unit, Hospital Epidemiology Centre, Centro Hospitalar Universitário São João, Porto, Portugal.; Instituto de Biomedicina de Sevilla (IBiS), Infectious Diseases and Microbiology Division, Hospital Universitario Virgen Macarena, Department of Medicine, University of Sevilla/CSIC, Sevilla, Spain., Arieti F; Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Pezzani MD; Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Gladstone BP; DZIF-Clinical Research Unit, Infectious Diseases, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Robotham JV; HCAI, Fungal, AMR, AMU & Sepsis Division, UK Health Security Agency, London, United Kingdom., Pouwels KB; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., Kingston R; HCAI, Fungal, AMR, AMU & Sepsis Division, UK Health Security Agency, London, United Kingdom., Carmeli Y; National Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Cassini A; Infectious Diseases Service, Lausanne University Hospital, Lausanne, Switzerland and Public Health Department, Canton of Vaud, Lausanne, Switzerland., Cecchini M; Head of Public Health, Health Division, OECD (Organisation for Economic Co-operation and Development), Paris, France., Drobniewski F; Department of Infectious Disease, Imperial College London, London, United Kingdom., Frost I; AstraZeneca, Eastbrook House, Cambridge, United Kingdom., Geurtsen J; Bacterial Vaccines Research & Early Development, Janssen Vaccines & Prevention B.V., Leiden, the Netherlands., Kronenberg A; Swiss Centre for Antibiotic Resistance, Institute for Infectious Diseases, University of Bern, Bern, Switzerland., Htay MNN; Department of Community Medicine, Faculty of Medicine, Manipal University College Malaysia, Melaka, Malaysia., Paul M; Infectious Diseases Institute, Rambam Health Care Campus; Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel., Rocha-Pereira N; Department of Medicine, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.; Infection and Antimicrobial Resistance Control and Prevention Unit, Hospital Epidemiology Centre, Centro Hospitalar Universitário São João, Porto, Portugal., Rodríguez-Baño J; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.; Instituto de Biomedicina de Sevilla (IBiS), Infectious Diseases and Microbiology Division, Hospital Universitario Virgen Macarena, Department of Medicine, University of Sevilla/CSIC, Sevilla, Spain., Scudeller L; Research and Innovation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Stewardson AJ; Department of Infectious Diseases, The Alfred Hospital and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia., Tacconelli E; Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Harbarth S; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, WHO Collaborating Center, Geneva, Switzerland., Vella V; GSK, Siena, Italy., de Kraker ME; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, WHO Collaborating Center, Geneva, Switzerland.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Nov; Vol. 29 (47).

Recurrent Clostridioides difficile infections in solid organ transplant recipients: The international CALIPSO study.

Autor: Tiseo G; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Yahav D; Infectious Diseases Unit, Sheba Medical Center, Ramat Gan, Israel., Atamna A; Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel., Avni T; Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel., Causse M; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Clinical Units of Microbiology and Infectious Diseases, Reina Sofia University Hospital, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Department of Agricultural Chemistry, Edaphology and Microbiology and Department of Medical and Surgical Science, University of Cordoba, Cordoba, Spain., Pérez-Nadales E; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Clinical Units of Microbiology and Infectious Diseases, Reina Sofia University Hospital, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Department of Agricultural Chemistry, Edaphology and Microbiology and Department of Medical and Surgical Science, University of Cordoba, Cordoba, Spain., Mularoni A; Infectious Diseases Unit, IRCCS-ISMETT (Mediterranean Institute for Transplantation and Advanced Specialized Therapies), Palermo, Italy., Reigadas E; Unit of Infectious Diseases, Hospital Universitario '12 de Octubre', Health Research Institute Hospital '12 de Octubre' (imas12), Department of Medicine, School of Medicine, Universidad Complutense, CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Olmedo-Samperio M; Unit of Infectious Diseases, Hospital Universitario '12 de Octubre', Health Research Institute Hospital '12 de Octubre' (imas12), Department of Medicine, School of Medicine, Universidad Complutense, CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Fernández-Ruiz M; Unit of Infectious Diseases, Hospital Universitario '12 de Octubre', Health Research Institute Hospital '12 de Octubre' (imas12), Department of Medicine, School of Medicine, Universidad Complutense, CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Palacios-Baena ZR; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Infectious Diseases and Microbiology Clinical Unit, University Hospital Virgen Macarena, Instute of Biomedicine of Seville (IBiS)/CSIC, Department of Medicine, University of Seville, Seville, Spain., Rodríguez-Baño J; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Infectious Diseases and Microbiology Clinical Unit, University Hospital Virgen Macarena, Instute of Biomedicine of Seville (IBiS)/CSIC, Department of Medicine, University of Seville, Seville, Spain., De Simone P; Liver Transplant Program, University of Pisa Medical School Hospital, Pisa, Italy., Biancofiore G; Division of Transplant Anesthesia and Critical Care, Department of Anesthesia, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy., Sabik EF; Infectious Diseases Instute, Rambam Health Care Campus, Haifa, Israel., Paul M; Infectious Diseases Instute, Rambam Health Care Campus, Haifa, Israel., Aguado JM; Unit of Infectious Diseases, Hospital Universitario '12 de Octubre', Health Research Institute Hospital '12 de Octubre' (imas12), Department of Medicine, School of Medicine, Universidad Complutense, CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Boggi U; Division of General and Transplant Surgery, University of Pisa, Pisa, Italy., Muñoz P; Unit of Infectious Diseases, Hospital Universitario '12 de Octubre', Health Research Institute Hospital '12 de Octubre' (imas12), Department of Medicine, School of Medicine, Universidad Complutense, CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Torres-Cisneros J; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Clinical Units of Microbiology and Infectious Diseases, Reina Sofia University Hospital, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Department of Agricultural Chemistry, Edaphology and Microbiology and Department of Medical and Surgical Science, University of Cordoba, Cordoba, Spain., Farcomeni A; Department of Economics and Finance, Tor Vergata University of Rome, Rome, Italy., Falcone M; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. Electronic address: marco.falcone@unipi.it.

Publikováno v: The Journal of infection [J Infect] 2024 Oct 05; Vol. 89 (6), pp. 106306. Date of Electronic Publication: 2024 Oct 05.

2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Complicated Intra-abdominal Infections: Diagnostic Imaging of Suspected Acute Diverticulitis in Adults and Pregnant People.

Autor: Bonomo RA; Medical Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.; Clinician Scientist Investigator, Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.; Departments of Medicine, Pharmacology, Molecular Biology and Microbiology, Biochemistry, and Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.; CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES) Cleveland, Ohio, USA., Tamma PD; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Abrahamian FM; Department of Emergency Medicine, Olive View-University of California Los Angeles (UCLA) Medical Center, Sylmar, California, USA.; David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Bessesen M; Department of Medicine, Veterans Affairs Eastern Colorado Health Care, Aurora, Colorado, USA.; Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, Colorado, USA., Chow AW; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Dellinger EP; Department of Surgery, University of Washington, Seattle, Washington, USA., Edwards MS; Division of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Goldstein E; RM Alden Research Laboratory, Santa Monica, California, USA., Hayden MK; Division of Infectious Diseases, Department of Medicine, Rush University Medical Center, Chicago, Illinois, USA., Humphries R; Division of Laboratory Medicine, Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Kaye KS; Division of Allergy, Immunology and Infectious Diseases, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA., Potoski BA; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania, USA., Rodríguez-Baño J; Division of Infectious Diseases and Microbiology, Department of Medicine, Hospital Universitario Virgen Macarena, University of Seville, Biomedicines Institute of Seville-Consejo Superior de Investigaciones Científicas, Seville, Spain., Sawyer R; Department of Surgery, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, USA., Skalweit M; Department of Medicine and Biochemistry, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA., Snydman DR; Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts, USA., Donnelly K; Clinical Affairs and Practice Guidelines, Infectious Diseases Society of America, Arlington, Virginia, USA., Loveless J; Clinical Affairs and Practice Guidelines, Infectious Diseases Society of America, Arlington, Virginia, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Oct 04; Vol. 79 (Supplement_3), pp. S109-S112.

2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Complicated Intra-abdominal Infections: Risk Assessment in Adults and Children.

Autor: Bonomo RA; Medical Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.; Clinician Scientist Investigator, Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.; Departments of Medicine, Pharmacology, Molecular Biology and Microbiology, Biochemistry, and Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.; CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES) Cleveland, Ohio, USA., Chow AW; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Abrahamian FM; Department of Emergency Medicine, Olive View-University of California Los Angeles (UCLA) Medical Center, Sylmar, California, USA.; David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Bessesen M; Department of Medicine, Veterans Affairs Eastern Colorado Health Care, Aurora, Colorado, USA.; Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, Colorado, USA., Dellinger EP; Department of Surgery, University of Washington, Seattle, Washington, USA., Edwards MS; Division of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Goldstein E; RM Alden Research Laboratory, Santa Monica, California, USA., Hayden MK; Division of Infectious Diseases, Department of Medicine, Rush University Medical Center, Chicago, Illinois, USA., Humphries R; Division of Laboratory Medicine, Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Kaye KS; Division of Allergy, Immunology and Infectious Diseases, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA., Potoski BA; Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania, USA., Rodríguez-Baño J; Division of Infectious Diseases and Microbiology, Department of Medicine, Hospital Universitario Virgen Macarena, University of Seville, Biomedicines Institute of Seville-Consejo Superior de Investigaciones Científicas, Seville, Spain., Sawyer R; Department of Surgery, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, USA., Skalweit M; Department of Medicine and Biochemistry, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA., Snydman DR; Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts, USA., Tamma PD; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Donnelly K; Clinical Affairs and Practice Guidelines, Infectious Diseases Society of America, Arlington, Virginia, USA., Kaur D; Clinical Affairs and Practice Guidelines, Infectious Diseases Society of America, Arlington, Virginia, USA., Loveless J; Clinical Affairs and Practice Guidelines, Infectious Diseases Society of America, Arlington, Virginia, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Oct 04; Vol. 79 (Supplement_3), pp. S88-S93.